ArticleThe Journal of pathology2022

Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.

Priyanka Tibarewal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.